Crestline Management, LP
- SEC CIK
- 0001536054
- Latest filing
- Aug 14, 2026
SNDX holding history
Syndax Pharmaceuticals Inc in every 13F filed by Crestline Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SNDX overviewAll 13F holders of SNDXFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −713,205−100.0% | Sold out | Holders |
| Q4 2024 | 713,205 | $9.43M | 0.3% | +284,667+66.4% | Added | Holders |
| Q3 2024 | 428,538 | $8.25M | 0.5% | +285,258+199.1% | Added | Holders |
| Q2 2024 | 143,280 | $2.94M | 0.2% | +39,570+38.2% | Added | Holders |
| Q1 2024 | 103,710 | $2.47M | 0.2% | +3,061+3.0% | Added | Holders |
| Q4 2023 | 100,649 | $2.18M | 0.2% | −33,815−25.1% | Reduced | Holders |
| Q3 2023 | 134,464 | $1.95M | 0.2% | +22,000+19.6% | Added | Holders |
| Q2 2023 | 112,464 | $2.35M | 0.3% | +17,255+18.1% | Added | Holders |
| Q1 2023 | 95,209 | $2.01M | 0.2% | +31,002+48.3% | Added | Holders |
| Q4 2022 | 64,207 | $1.63M | 0.2% | +656+1.0% | Added | Holders |
| Q3 2022 | 63,551 | $1.53M | 0.2% | +3,000+5.0% | Added | Holders |
| Q2 2022 | 60,551 | $1.17M | 0.2% | −2,965−4.7% | Reduced | Holders |
| Q1 2022 | 63,516 | $1.10M | 0.1% | +63,516 | New | Holders |